Principia Biopharma Inc Asset Turnover Ratio (PRNB), as of second quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Principia Biopharma Inc   (NASDAQ: PRNB)
 

Principia Biopharma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Principia Biopharma Inc asset turnover ratio, the ability of Principia Biopharma Inc 's assets to generate revenue in the second quarter 2020, increased sequentially to 0.15 in the second quarter (Jun 30 2020), PRNB's balance sheet remain strong.

Within sector Principia Biopharma Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2020 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRNB Asset Turnover Ratio (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Asset Change 100.39 % 103.09 % 95.75 % -13.21 % 324.88 %
Y / Y Revenue Change 66.67 % - - - 131 %
Asset Turnover Ratio (TTM) 0.15 - - - 0.42
PRNB's Total Ranking # # # # #
Seq. Asset Change 6.24 % -5.22 % 119.85 % -9.49 % 7.67 %
Seq. Revenue Change - - - - 481.4 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




PRNB Company Profile • Back to PRNB Efficiency Comparisons • Compare PRNB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2020 Assets at quarter ending Jun 30 2020
United Therapeutics Corporation  0.35 $ 1,430.900  Millions$ 4,039.575  Millions
Soligenix inc   0.35 $ 3.370  Millions$ 9.554  Millions
Surgery Partners Inc   0.35 $ 1,784.900  Millions$ 5,068.000  Millions
Quanterix Corporation  0.35 $ 59.719  Millions$ 169.685  Millions
Bionano Genomics Inc   0.35 $ 8.420  Millions$ 23.930  Millions
Cidara Therapeutics Inc   0.35 $ 26.837  Millions$ 77.043  Millions
Flexion Therapeutics Inc   0.35 $ 81.018  Millions$ 234.568  Millions
Immutep Limited  0.34 $ 11.072  Millions$ 32.119  Millions
Siga Technologies Inc  0.34 $ 55.344  Millions$ 161.274  Millions
Supernus Pharmaceuticals inc   0.34 $ 424.291  Millions$ 1,237.019  Millions
Cumberland Pharmaceuticals Inc   0.34 $ 34.170  Millions$ 100.814  Millions
Aspira Women s Health inc   0.34 $ 4.559  Millions$ 13.451  Millions
Assertio Holdings inc   0.34 $ 155.906  Millions$ 462.259  Millions
Anika Therapeutics Inc   0.34 $ 125.544  Millions$ 372.432  Millions
Avinger Inc   0.34 $ 8.699  Millions$ 25.879  Millions
Orthopediatrics Corp  0.33 $ 69.645  Millions$ 209.567  Millions
Alexion Pharmaceuticals Inc   0.33 $ 5,536.800  Millions$ 16,802.825  Millions
Sangui Biotech International Inc  0.33 $ 0.029  Millions$ 0.088  Millions
Immunogen inc   0.33 $ 86.457  Millions$ 264.484  Millions
Misonix Inc   0.33 $ 62.484  Millions$ 191.818  Millions
Htg Molecular Diagnostics Inc  0.32 $ 14.394  Millions$ 44.319  Millions
Becton Dickinson And Company  0.32 $ 16,917.000  Millions$ 52,751.250  Millions
Biocryst Pharmaceuticals Inc   0.32 $ 49.194  Millions$ 154.269  Millions
Exact Sciences Corporation  0.32 $ 1,131.069  Millions$ 3,548.474  Millions
Endo International Plc  0.32 $ 3,002.219  Millions$ 9,423.852  Millions
Bristol myers Squibb Company  0.31 $ 34,862.000  Millions$ 111,184.500  Millions
Ionis Pharmaceuticals Inc   0.31 $ 940.476  Millions$ 3,074.491  Millions
Medtronic Plc  0.31 $ 27,927.000  Millions$ 91,335.500  Millions
Apyx Medical Corp  0.31 $ 25.331  Millions$ 82.908  Millions
Reshape Lifesciences Inc  0.30 $ 12.056  Millions$ 39.635  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.